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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Reagents 
Fresh bovine (calf) brains, from Manning’s Beef (Pico Rivera, CA), were brought to the 
laboratory on ice, and were immediately processed for Ntaq1 purification. Mouse cDNA clones 
(RIKEN cDNA 2410187C16 gene (NTAQ1, clone ID 1514917, Accession No. BC051524), 
HEBP2 (clone ID 5668921, 3599858), and USP1 (clone ID 3585191)) were from 
OpenBiosystems (Huntsville, AL). The plasmid pBirAcm, a derivative of pACYC184 that 
encoded the IPTG-inducible BirA biotin ligase of E. coli, was purified from E. coli AVB101 
(Avidity, Denver, CO). Polyclonal anti-GFP antibody and monoclonal anti-FLAG M2 antibody 
were from Sigma (St. Louis, MO). The synthetic (purified by HPLC) peptides NHGSGAW, 
YHGSGQW, QHGSGAW, KQGSGAW, QDGSGAW, QYGSGAW, QKGSGAW, QPGSGAW, 
Ac-QHGSGAW, and QLGSGAW were from Genscript (Piscataway, NJ). Each of these peptides 
was more than 90% pure, according to HPLC and mass spectrometric (MS) analyses. Zeocin, the 
plasmid pPICZα-C, and the host strain of Pichia pastoris X-33 (Mut+) were from Invitrogen 
(Carlsbad, CA). Transfections of mouse NIH-3T3 and other cell lines were carried out using 
Lipofectamine Plus or Lipofectamine2000 (Invitrogen). The Ate1-encoded mouse Arg-tRNA-
protein transferase (R-transferase) was expressed in E. coli from the plasmid pWHQ91 and 
purified as described (Hu et al., 2008). Ammonia assay kit was from Megazyme (Wicklow, 
Ireland.) 
 
Reporter Proteins 
 Nucleotide sequences encoding E. coli DHFR bearing the C-terminal extension 
GGGLNDIFEAQKIEWHE (called Biotin-AviTag and denoted below as “bt”), were constructed 
using standard methods and cloned into SacII/HindIII-cut pH10UE (Beckett et al., 1999; 
Catanzariti et al., 2004). The resulting reporter protein, His10-Ub-XLTKCEV-DHFRbt (X = Q; 
E; N; EQ; MQ; GQ; REQ), denoted as His10-Ub-X-DHFRbt, also contained an N-terminal 
extension that began with the His10-Ub moiety and was followed by the sequence XLTKCEV, 
derived from EQLTKCEV, the N-terminal sequence of α-lactalbumin, a reporter in R-transferase 
assays (Hu et al., 2006). The resulting plasmids, termed pH10UE-X-DHFR-BAT, encoded His10-
Ub-X-DHFRbt reporters in which a Lys residue in the “bt” tag was biotinylated by the BirA 
biotin-protein ligase in E. coli. 
 To express His10-Ub-X-DHFRbt proteins, transformation-competent BL21(DE3) E. coli 
were transformed at first with pBirAcm, which expressed the BirA E coli biotin-protein ligase, 
followed by transformations with one of pH10UE-X-DHFR-BAT plasmids, selection for 
ampicilin/chloramphenicol resistance, and isolation of individual transformants. An overnight 
culture of transformed cells in LB was split 1:100 into 250 ml of LB medium containing 
ampicilin (50 µg/ml) and chloramphenicol (34 μg/ml), followed by growth at 37°C until A600 of 
~0.4. Expression of both biotin ligase and a His10-Ub-X-DHFRbt fusion was induced with IPTG 
(0.5 mM), and was carried out for 5 hr at 37°C, with biotin added 15 min before IPTG induction 
to the final concentration of 0.2 mM. His10-Ub-X-DHFRbt was purified from harvested cells 
using the Qiagen Ni-NTA resin and QIA-Express protocol (Qiagen, Valencia, CA). Briefly, 
frozen cell pellets were thawed and resuspended in Ni-NTA binding buffer (0.3 M NaCl, 20 mM 
imidazole, 5 mM β-mercaptoethanol, 50 mM NaH2PO4-Na2HPO4, pH 8.0) containing lysozyme 
(1 mg/ml) and EDTA-free protease inhibitors (Roche, Palo Alto, CA). The lysate was sonicated, 
centrifuged at 10,000g for 30 min at 4°C, followed by incubation for 1 hr at 4°C with Ni-NTA 
resin pre-equilibrated with binding buffer. The resin was washed with binding buffer, followed 
by a second wash with binding buffer containing 50 mM imidazole. The fusion protein was 
eluted with binding buffer containing 0.25 M imidazole, which was then removed using gel 
filtration on PD-10 column (GE Healthcare, Piscataway, NJ) equilibrated with 10% glycerol, 
0.15 M NaCl, 10 mM β-mercaptoethanol, 20 mM Tris-HCl (pH 7.4). Purified, biotinylated His10-
Ub-X-DHFRbt proteins were stored at -80ºC in small samples, to be thawed just once. 
 
 
 
NtQ-Amidase Assays with X-DHFRbt Reporters 
 Assays with crude extracts and chromatographic fractions. Mouse NIH-3T3 cells were 
grown on 10-cm plates at 37°C in Dulbecco's modified Eagle's medium (DMEM) (Mediatech, 
Manassas, VA) containing 10% heat-inactivated fetal bovine serum and supplemented with 
penicillin/streptomycin/glutamine. Eight plates of cells at ~80% confluency (~1 x 107 cells per 
plate) were harvested by mild trypsinization, with subsequent inhibition of trypsin by DMEM. 
The suspension was centrifuged at 300g for 5 min, the cell pellet was washed twice with cold 
phosphate-buffered saline (PBS) and stored at -80ºC. For NtQ-amidase activity assays, the cell 
pellet was thawed and resuspended in 1 ml of lysis buffer (10% glycerol, 0.05% NP40, 0.15 M 
NaCl, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF; from a freshly 
prepared 1 M stock solution in isopropanol), 50 mM HEPES (pH 7.5), EDTA-free mini protease 
inhibitor tablet (Roche)). The extract was clarified by centrifugation at 13,000g for 20 min at 
4°C, and NtQ-amidase activity was measured in the supernatant (8 mg/ml of total protein, 
according to the Bradford assay (BioRad, Hercules, CA)) as described below. 
 Mouse tissues were another source of crude extracts for NtQ-amidase activity assays. All 
experiments with mice were approved by the Institutional Animal Care and Use Committee at 
the California Institute of Technology. Wild type C57BL/6 mice were sacrificed through 
inhalation of CO2, and several tissues were isolated, followed by washes with cold PBS. The 
tissues were frozen in liquid N2, then disrupted using a pestle in the presence of liquid N2, with 
subsequent addition of the above lysis buffer, clarification of the extract by centrifugation as 
described above, and adjustment of the total protein concentration in the supernatant to 8 mg/ml. 
Prior to NtQ-amidase assays, all extracts were passed through protein desalting spin columns 
(Pierce, Rockford, IL) equilibrated with wash buffer (5% glycerol, 0.2 M NaCl, 1 mM DTT, 20 
mM NaH2PO4-Na2HPO4, pH 7.8). 
 To measure the NtQ-amidase activity, purified His10-Ub-X-DHFRbt reporters were 
immobilized on neutravidin beads (Pierce) shortly before beads’ incubation with the extracts 
described above. NtQ-amidase activity was measured using a 14C-arginylation assay (see the 
main text and Figure 1B). A slurry of neutravidin beads (40 μl) was washed 3 times with wash 
buffer (5% glycerol, 0.2 M NaCl, 1 mM DTT, 20 mM NaH2PO4-Na2HPO4, pH 7.8) prior to 
incubation with ~30 μl (60 μg) of a biotinylated reporter protein (~2 mg/ml) for 1 hr at room 
temperature (RT), with gentle mixing. The His10-Ub moiety of His10-Ub-X-DHFRbt was cleaved 
off by incubation with purified deubiquitylating (DUB) enzyme USP2cc (2 μg) (Catanzariti et 
al., 2004) for 5 min at RT, and the beads-bound X-DHFRbt, bearing a new N-terminal residue (X 
= M; Q; E; N; MQ; EQ; GQ), was immediately incubated with 0.1 ml of an extract to be tested 
(0.8 mg of total protein) for 1 hr at RT. (In developing these assays, we found that the 
preliminary deubiquitylation step could not be carried out long in advance of subsequent steps, 
because the resulting exposure of N-terminal Gln in a reporter such as, for example, Q-DHFRbt, 
led to a slow, possibly nonenzymatic deamidation of N-terminal Gln, even if a deubiquitylated 
reporter was stored at -80°C.) The beads were washed 3 times with wash buffer, followed by the 
addition (to ~20 μl of a pellet of wet beads) of 40 μl of the arginylation assay mixture that 
contained 5 mM ATP, 0.15 M KCl, 10 mM MgCl2, 5 mM DTT, 50 mM Tris-HCl (pH 8.0), and 
also purified mouse R-transferase (50 μg/ml), total E coli tRNA (0.75 mg/ml; Sigma), E coli 
aminoacyl-tRNA synthetases (800 units/ml; Sigma), and 8 μM 14C-Arg (368 mCi/mmol, GE 
Healthcare). For an outline of this coupled deamidation-arginylation assay, see Figure 1B. After 
40 min at RT, the beads were washed 10 times with washing buffer, followed by the addition of 
SDS sample buffer (30 μl), heating at 95°C for 5 min, fractionation by SDS-15% PAGE, 
autoradiography and quantitation, using PhosphorImager (Molecular Dynamics, Sunnyvale, CA). 
To minimize the loss of beads during washes, they were placed into a microspin column (Pierce) 
and washed in it. Before the addition of SDS sample buffer, the beads were transferred to a 
microcentrifuge tube. 
 Assays of NtQ-amidase (Ntaq1) during its purification were carried out in 
chromatographic fractions largely as described above, with the following modifications. 14C-Arg 
was replaced by a mixture of unlabeled Arg (5 μM) and 3H-Arg (~0.1 μM, 58 Ci/mmol, MP 
Biomedicals, Solon, OH). After carrying out the arginylation reaction, the beads (containing an 
immobilized reporter protein) were washed 10 times with wash buffer. A washed pellet was 
suspended in a toluene-based scintillation cocktail, and the amount of 3H determined using a 
scintillation counter. 
 Assays of mouse Ntaq1 purified from mouse cells, or from mouse Ntaq1-expressing 
Pichia pastoris. The assay was initiated by a 5-min treatment of immobilized of His10-Ub-X-
DHFRbt (10 μg, X = Q, N) with the purified USP2cc DUB enzyme, as described above. 
Thereafter purified mouse Ntaq1 was added, to the final concentration of 20 μg/ml, followed by 
incubation for 20 min at RT. Thereafter 30 μl of the 14C-arginylation-assay mixture was added, 
and the incubation was continued for another 30 min, followed by SDS-15% PAGE, 
autoradiography, and quantitation using PhosphorImager. 
 Effects of Alkylation Reagents on the Activity of Ntaq1. Thiol-reducing reagents were 
removed from samples containing purified mouse Ntaq1 using desalting spin column (Pierce) 
equilibrated with reaction buffer (5% glycerol, 0.15 M NaCl, 20 mM Tris-HCl, pH 7.4). Thus 
treated Ntaq1, at the final concentrations of 80 μg/ml, 8 μg/ml, or 0.8 μg/ml, was incubated for 
30 min with iodoacetamide (5 mM) or N-ethylmaleimide (5 mM) in the same buffer at RT, in the 
dark. The reaction was quenched by the addition of DTT to the final concentration of 20 mM. 
Samples (5 μl) of treated Ntaq1 were then assayed for NtQ-amidase activity as described above. 
 
NtQ-Amidase Assay with Synthetic Peptides 
 The availability of highly purified mouse Ntaq1 from Pichia pastoris (see below) made 
possible an entirely different NtQ-amidase assay, which utilized 7-residue peptides XZ-GSGAW 
(XZ = QH; QK; QL; QD; QY; QP; KQ; YH; NH; Ac-QH) as reporters (Figure 4C-E). In this 
“Q-peptide” assay, deamidation of, for example, Gln-HGSGAW was measured by quantifying 
the production of ammonia (NH3). It was detected through the presence of NADH-dependent 
glutamate dehydrogenase (Figure 4C). The consumption of NADH, measured through a decrease 
of A340, was used to measure the formation of ammonia and thus the activity of NtQ-amidase. 
The ammonia assay kit was from Megazyme (Wicklow, Ireland). Briefly, either free Gln or the 
above synthetic peptides were preincubated with NADH (0.25 M), oxoglutarate (7 mM) and 
glutamate dehydrogenase (2.4 U) in 1 mM DTT, buffer (70 mM triethanolamine, pH 8.0) at RT 
for ~ 8 min, until A340 was stable. The reaction was initiated by addition of purified mouse Ntaq1 
(5 μl; 0.2 mg/ml), to the final concentration of 1.7 μg/ml in the total of volume of 575 μl, 
followed by incubation at RT for 10 min. The rate of ammonia formation was measured by the 
decrease of A340 (owing to the consumption of NADH; ε340 = 6300 M-1cm-1). A typical assay 
utilized peptide substrates at 0.1 mM and purified mouse Ntaq1 at 1.7 μg/ml. Assays with Ntaq1 
mutants were carried out using the Gln-HGSGAW substrate. 
 
Purification of Bovine Ntaq1 NtQ-Amidase 
 Preparation of Extract and Ammonium Sulfate Precipitation. A freshly isolated calf brain 
(400 g) was washed in 2 liters of cold PBS and suspended in 800 ml of cold lysis buffer (10% 
glycerol, 0.45 M NaCl, 2 mM DTT, 50 mM Tris-HCl, pH 7.4) containing EDTA-free protease 
inhibitor (Roche). The brain tissue was minced in an electrical blender and thereafter extracted in 
a prechilled glass-teflon homogenizer. The brain extract was clarified by centrifugation in the 
Sorvall GSA rotor at 6,500 rpm (7,000g) for 15 min at 4°C, and was further clarified by 
centrifugation in the Type-45 Ti rotor (Beckman) at 28,500 rpm (63,000g) for 80 min at 4°C. 
Proteins in the supernatant were precipitated by the addition of ammonium sulfate ((NH4)2SO4) 
powder to ~75% saturation (3 M) at 4°C. The precipitate was collected by centrifugation at 6,500 
rpm in a the GSA rotor for 20 min, dissolved in 200 ml of 10% glycerol, 20 mM NaCl, 1 mM 
DTT, 50 mM NaH2PO4-Na2HPO4, pH 7.4) and dialyzed against the same buffer overnight at 
4°C, followed by centrifugation at 5,000 rpm (SS-34 rotor) for 10 min and filtration of the 
supernatant through a 0.45 µm syringe filter (Millipore, Billerica, MA). 
 Chromatographic Purification of Ntaq1. All chromatography was carried out using 
Pharmacia Fast Protein Liquid Chromatography (FPLC) apparatus at 4ºC. At each stage, 
fractions contain more than 50% of the peak NtQ-amidase activity were combined for the next 
purification step. The brain-derived sample after (NH4)2SO4 precipitation (see above; 1 g of total 
protein) was applied to a 150-ml column (bed volume) of DEAE Fast Flow anion exchange resin 
(GE HealthCare) that had been preequilibrated in buffer A (10% glycerol, 20 mM NaCl, 1 mM 
DTT, 50 mM NaH2PO4-Na2HPO4, pH 8.0). The column was washed with buffer A until A280 
returned to its base-line level. The adsorbed proteins were eluted with a 1.2 liter of linear NaCl 
gradient, from 20 mM to 0.5 M NaCl in buffer A. The flow rate was 1 ml/min, and 10-ml 
fractions were collected. The NtQ-amidase activity assay was carried out as described above, 
using 0.3 ml of each fraction. Fractions containing 50% or more of the peak NtQ-amidase activity 
were pooled and dialyzed against buffer B (5% glycerol, 1 M (NH4)2SO4 1 mM DTT, 50 mM 
NaH2PO4-Na2HPO4, pH 7.4). The resulting sample was applied to a TOYOPEARL Phenyl-605S 
column (25 ml bed volume; Tosoh, Japan). The column was washed with buffer B to remove 
unbound proteins, and the bound proteins were eluted with a 300-ml linear gradient of 
(NH4)2SO4, from 1.0 to 0 M. Fractions of 5 ml were collected, and 0.1 ml of each fraction was 
assayed for NtQ-amidase activity, after desalting, using protein desalting spin columns 
equilibrated with wash buffer (5% glycerol, 0.2 M NaCl, 1 mM DTT, 20 mM NaH2PO4-
Na2HPO4, pH 7.8). Fractions containing NtQ-amidase were pooled (using the 50%-threshold 
criterion above) and concentrated to the final volume of 6 ml, using Centricon Plus-70 (MWCO 
10 KDa, Millipore). The resulting sample was split into two halves, and each of them (3 ml) was 
subjected to an identical fractionation by gel filtration, using HighLoad Superdex75 prepgrade 
column (GE Healthcare) pre-equilibrated with buffer C (5% glycerol, 1 mM DTT, 50 mM 
NaH2PO4-Na2HPO4, pH 7.4). The flow rate was 0.5 ml/min. 2-ml fractions were collected, and 
50 µl of each fraction was assayed for NtQ-amidase activity. Active fractions were pooled and 
dialyzed against buffer D (5% glycerol, 10 mM NaCl, 1 mM DTT, 20 mM Tris-HCl, pH 8.0). 
The resulting sample was loaded onto a MonoQ HR 5/5 column (GE Healthcare) equilibrated 
with buffer D. The column was washed with 5 ml of buffer D, and the proteins were eluted with 
a 20-ml gradient of NaCl, from 10 mM to 0.5 M NaCl in buffer D. The flow rate was 0.5 ml/min 
and 0.2-ml fractions were collected. Each fraction was assayed for NtQ-amidase activity, and was 
also analyzed by SDS-15% PAGE, with both Coomassie and silver staining. The fraction with 
highest NtQ-amidase activity was subjected to gel filtration on a Superose-12 10/300 GL column 
(GE Healthcare) equilibrated with buffer E (5% glycerol, 0.15 M NaCl, 1 mM DTT, 20 mM 
Tris-HCl, pH 8.0). The flow rate was 0.5 ml/min, with 0.2-ml fractions collected, and with 5 µl 
of each fraction assayed for NtQ-amidase activity. Thereafter proteins in each fraction were 
precipitated with 20% CCl3COOH, fractionated by SDS-15% PAGE, and visualized by 
Coomassie and silver staining. 
 Trypsin In-Gel Digestion and Mass Spectrometric Analysis. The major bands in the peak 
NtQ-amidase activity fraction of Superose-12 column (Figure 2D), were excised and in-gel 
digested with trypsin, using the Trypsin Profile IGD kit (Sigma) and manufacturer-supplied 
protocol. The digest was fractionated using an in-line Vydac C18 capillary column (0.1 mm 
(internal diameter) by 6 cm) connected to the Eksigent Nano LC-2D HPLC system, and 
thereafter analyzed on QStar-XL Pulsar quadrupole-TOF mass spectrometer (Applied 
Biosystems). The MS spectra were analyzed against mammalian protein databases using Mascot 
software. In a second, independent fractionation-and-sequencing experiment, a fraction adjacent 
to the fraction from the same Mono-Q column (see Figure 1C) that supplied the peak-activity 
Ntaq1 fraction for the Superose-12 step (Figure 2C, D) was subjected to gel filtration on 
Superose-12. Proteins in collected fractions were fractionated by SDS-PAGE but stained, this 
time, with Coomassie. Only one major band, at ~26 kDa (see the main text and Figure 2C, D), 
was seen in that (second) fractionation. That band was excised and processed for MS-based 
sequencing as described above. Both of these independent fractionation/sequencing steps 
produced the same results, yielding peptides that were specific for the bovine counterparts of 
human Hebp2 and human C8orf32 (Ntaq1).  
 
Expression of Mouse Ntaq1 in Pichia pastoris and Purification of Recombinant Ntaq1 
 The mouse Ntaq1 ORF was amplified by PCR, using p425MET25-Ntaq1f as the 
template. The product was digested with ClaI/SalI and subcloned into ClaI/SalI-cut pPICZα-C 
vector (InVitrogen), in-frame and between the sequence encoding the N-terminal signal peptide 
of the α-mating factor and the sequence encoding the C-terminal His6 tag. The resulting plasmid, 
pPICZα-mNTAQ1, which encoded His6-tagged mouse Ntaq1 (Ntaq1H6), was linearized by SacI 
prior to transforming P. pastoris X-33 (Mut+), using electroporation (Gene Pulser; Bio-Rad, 
Hercules, CA). Transformed cells were plated onto YPDS (1% yeast extract, 2% peptone, 2% 
dextrose, 1 M sorbitol) agar plates containing 0.1 mg/ml Zeocin. The resulting transformants 
were screened using PCR, P. pastoris genomic DNA, and the pPICZα specific primers 5′AOX1 
and 3′AOX1 (Table S2). 
 A single colony of transformed P. pastoris was inoculated into 50 ml of BMY medium 
(1% yeast extract, 2% peptone, 100 mM potassium phosphate, pH 6.0, 1.24% YNB (Yeast 
Nitrogen Base Broth), 4 x10-5% biotin) containing 1% glycerol. The culture was grown at 30°C 
until A600 of 4-6 (~16 hr). The cells were collected by centrifugation at RT and resuspended to 
A600 of 1.0 in 250 ml of BMY medium without glycerol, followed by a further growth at 30°C 
for ~60 hrs. Methanol was used as a carbon source at this stage. It was added to the final 
concentration of 0.5% every 24 hr to maintain the induction of the PAOX1 promoter. The culture 
was harvested after growing on methanol for ~60 hrs. Cells were pelleted by centrifugation at 
3,000g for 20 min, and the supernatant was further clarified by filtration, using a 0.45 μm filter 
unit (Nalgene, Rochester, NY). 
 Proteins in the clarified supernatant were precipitated by the addition of (NH4)2SO4 
powder to 85% saturation at 4°C. The precipitate was collected by centrifugation and 
resuspended in Ni-NTA binding buffer (10% glycerol, 20 mM imidazole, 0.3 M NaCl, 5 mM 
β-mercaptoethanol, 50 mM NaH2PO4-Na2HPO4, pH 8.0), followed by incubation for 1 hr at 4°C 
with Ni-NTA-agarose beads (Qiagen) that had been pre-equilibrated with binding buffer. The 
beads were washed with binding buffer, followed by a second wash with binding buffer 
containing 50 mM imidazole. Mouse Ntaq1H6 was eluted with binding buffer containing 250 mM 
imidazole, followed by overnight dialysis at 4°C against gel filtration buffer (10% glycerol, 0.15 
M NaCl, 10 mM β-mercaptoethanol, 20 mM Tris-HCl, pH 7.4), and concentrated using 
Centricon (Millipore, 10 kDa cutoff). The concentrated protein sample was fractionated by gel 
filtration on a High-Load Superdex 200 column that had been equilibrated with five column 
volumes of gel filtration buffer. 2-ml fractions were collected. Peak Ntaq1H6-containing fractions 
were pooled, concentrated using Centricon (Millipore, 10 kDa cutoff) to 1 mg/ml and stored in 
multiple samples at -80°C. Total protein concentration was measured using Bradford assay 
(BioRad), with bovine serum albumin as the standard. 
 
Plasmids for Expression of Mouse Ntaq1 in S. cerevisiae 
 DNA fragments encoding the S. cerevisiae Nta1 NtN,Q-amidase and the mouse Ntan1 
NtN-amidase were amplified by PCR from S. cerevisiae genomic DNA (Baker and Varshavsky, 
1995) and from the previously constructed pSG61 plasmid (Grigoryev et al., 1996), respectively. 
DNA fragments encoding the mouse Ntaq1 NtQ-amidase of the present work and the mouse 
heme-binding protein 2 (Hebp2) were amplified from mouse cDNA clones purchased from 
OpenBiosystems (clone IDs 5668921 and 1514917, respectively). These sequences were linked 
to DNA encoding the C-terminal FLAG epitope (DYKDDDDK), using the corresponding 
PCR-amplified BamHI/XhoI DNA fragments and subcloning the resulting ORFs (downstream of 
the S. cerevisiae PMET25 promoter) into BamHI/XhoI-cut high-copy vector p425MET25 
(Mumberg et al., 1994). These procedures yielded the plasmids p425MET25-scNta1f, 
p425MET25-mmNtan1f, p425MET25-mmHebp2f and p425MET25-mmNtaq1f. 
 
nta1∆ S. cerevisiae and β-Galactosidase Assay 
 The S. cerevisiae nta1∆ strain WHQ8 was constructed in the background of JD52 (MAT 
α ura3-52 lys2-801 trp1- 63 his3- 200 leu2-3) by disrupting the NTA1 gene with the KANR 
kanamycin resistance marker (Knop et al., 1999; Longtine et al., 1998). KANR was amplified 
from the pFA6a-KANMX6 plasmid using the 5’ primers HW-4-44A/HW-4-44A1 and the 3’ 
primers HW-4-44B/HW-4-44B1 (Table S2). The resulting DNA fragment contained KANR 
flanked by 60 bp segments that are present, respectively, upstream and downstream of the NTA1 
ORF. This fragment was transformed into JD52 S. cerevisiae. Kanamycin-resistant transformants 
were isolated and the correct integration of KANR into NTA1 was verified by PCR of genomic 
DNA, using primers HW-4-44B/HW-4-57A (Table S2) that comprised a 21-nucleotide sequence 
179 bp upstream of scNTA1. 
 Assays for βgal activity were carried out with WHQ8 (nta1∆) S. cerevisiae transformed 
with pUB23-X (X = Met, Asp, Asn, Glu, or Gln) that expressed Ub-X-βgal reporter proteins 
(they are cotranslationally processed to X-βgals in vivo) from the S. cerevisiae PGAL10 promoter 
(Bachmair et al., 1986; Varshavsky, 2005). The resulting strains were subsequently transformed 
with either p425MET25-Nta1f, p425MET25-Ntan1f, p425MET25-Ntaq1f, or the p425MET25 
control plasmid. Cells were grown overnight at 30°C in synthetic (SD) medium lacking Ura and 
Leu, and containing 4% raffinose. Expression of Ub-X-βgals was induced at A600 of ~0.4 by the 
addition of galactose to the final concentration of 2%, followed by a further growth, until A600 of 
0.8-1. Cells in a 1 ml culture were pelleted by centrifugation and resuspended in 1 ml of H2O. 
After measuring A600 of the suspension, 0.1 ml samples were diluted to 0.8 ml with Z buffer (10 
mM KCl, 1 mM MgSO4, 50 mM β-mercaptoethanol, 0.1 M Na2HPO4-NaH2PO4, pH 7.0). 
Chloroform (80 μl) and 0.1% SDS (20 μl) were then added. The suspension was vortexed for 20 
sec and incubated at 30°C for 10 min, followed by the addition of 20 μl of chlorophenol red-β-D-
galactopyranoside (CPRG, from a freshly prepared stock solution of 34 mg/ml in Z buffer). The 
reaction was stopped with 0.5 ml of 1 M Na2CO3, followed by a brief spin in a microcentrifuge 
and measurements of A578 in the supernatant. The number of units was calculated as follows: 
βgal (units) = 1,000 x A578/(t x V x A578 ); t is reaction time (min), and V the sample volume (ml). 
Relative βgal activities were then calculated, with the activity of Met-βgal taken as 100%. 
 
Site-Directed Mutagenesis 
 Alterations of specific residues in mouse Ntaq1 (C23 to A; C28 to A; C30 to A; C38 to 
A; E39 to Q; D81 to N; H83 to A; D147 to N; and H170 to A) were carried out using two-step 
PCR (Ke and Madison, 1997), with pPICZα-mNtaq1 as a template. The mutant Ntaq1 ORFs 
were cloned into ClaI/SalI-cut pPICZα-C vector, expressed in P. pastoris and affinity-purified as 
described above. 
 
N-terminal Sequencing of Reporter Proteins 
 Purified His10-Ub-XLTKCEV-DHFR-BioTag fusion proteins (20 μg, X = MQ; EQ; GQ; 
E; Q; N) were incubated with 2 μg of purified USP2cc deubiquitylating enzyme in 20 μl of 5% 
glycerol 0.15 M NaCl, 1 mM DTT, 20 mM Tris-HCl (pH 7.4) for 5 min at RT to cleave off the 
N-terminal His10-Ub moiety. Thereafter the samples were incubated for 30 min at RT with 
purified wild-type (C-terminally His6-tagged) mouse Ntaq1H6 (final concentration 0.2 mg/ml), 
followed by the addition of SDS sample buffer, heating at 70ºC for 5 min, and SDS-Tris 15% 
PAGE. Fractionated proteins were electroblotted onto PVDF membrane (BioRad, 0.2 μm, 
sequencing grade) in 10% MeOH, 10 mM CAPS buffer (N-cyclohexyl-3-aminopropanesulfonic 
acid, pH 10. The bands of X-DHFRbt proteins were excised and subjected to N-terminal 
sequencing by Edman degradation (Ausubel et al., 2006). 
 
Transglutaminase Assay 
 His10-Ub-XLTKCEV-DHFRbt fusion proteins (X = Q; N) were expressed in E. coli as 
described above except that biotin was omitted from the growth medium. His10-Ub-XLTKCEV-
DHFRbt (25 μg), purified as described above, was treated with purified USP2cc (2 μg) for 5 min 
at room temperature (RT) to remove the His10-Ub moiety. Immediately thereafter, the samples 
were incubated for 1 hr at RT with 2 mM biotin-cadaverine and 5 μg of purified (from P. 
pastoris) mouse Ntaq1, in the total volume of 30 μl. The incubation buffer was 5% glycerol, 0.15 
M NaCl, 1 mM DTT, 20 mM Na-phosphate (pH 6.2) or, alternatively, the same buffer but with 
50 mM Tris-HCl, at pH 7.5 or 8.2. The incubated samples were subjected to SDS-15% PAGE as 
described above, followed by immunoblotting with streptavidin-HPR (1:1,000 dilution; 
Invitrogen). As described in the main text, no transglutaminase activity was detected using this 
assay with the Ntaq1 NtQ-amidase and two substrates described above. 
 
Construction and Use of Ntaq1-EGFP Reporter 
 The mouse Ntaq1 ORF was subcloned into XhoI/SacII-cut pEGFP-N1 (Clontech) to 
yield pNTAQ1-EGFP-N1, which expressed Ntaq1-EGFP from the PCMV promoter. NIH-3T3 
cells were grown to ~60% confluence on glass coverslips for 24 hr prior to transfection with 
either the EGFP-expressing control plasmid pEGFP-N1 or pNTAQ1-EGFP-N1, using 
Lipofectamine (Invitrogen) and the manufacturer-supplied protocol. Briefly, cells were incubated 
for 5 hr at 37°C in serum-free DMEM containing DNA and Lipofectamine. The serum-free 
medium was replaced by complete medium, and the cells were grown for additional 36 hr. Cells 
were then fixed with 4% HCHO in PBS, and EGFP fluorescence patterns were examined using 
Zeiss Axiophot microscope. 
 
RNAi Experiments 
 “RNAi Designer” (www.invitrogen.com/rnai, Invitrogen) was used to design pre-miRNA 
sequences based on mouse Ntaq1 mRNA (Acc.# BC051524) as a target sequence. Four potential 
miRNA sequences were chosen and two complementary single-stranded DNA oligonucleotides 
for each sequence were synthesized (Table S2), with one of them encoding an miRNA of 
interest. Each pair of complementary oligonucleotides was annealed to generate a double-
stranded oligonucleotide (ds-oligo) and subcloned into the cloning site of BLOCK-iT Pol II miR 
RNAi Expression Vector (pcDNA™6.2-GW/EmGFP-miR, Invitrogen) that is flanked on either 
side with sequences from murine miR-155 to allow proper processing of the engineered pre-
miRNA sequence (Lagos-Quintana et al., 2002). Four plasmids were constructed: pKP220, 
pKP221, pKP222, pKP223, expressing sequences A, B, C and D, respectively (Table S2). The 
constructs (including pcDNA™6.2 GW/miR, a negative control plasmid) were transfected into 
mouse NIH-3T3 cells using Lipofectamine-2000 (Invitrogen), and cell lines containing 
integrated plasmids were isolated on DMEM medium (plus 10% fetal bovine serum) containing 
5 μg/ml blasticidin (Invitrogen). At least six independent cell clones were picked and expanded 
for each construct. An affinity-purified antibody to mouse Ntaq1 (see below) was used to 
determine the relative levels of Ntaq1 in the resulting cell lines. Figure S4A shows the results 
with a cell line, termed A2, that expressed the Ntaq1-specific pre-miRNA “A” and exhibited a 
strongest decrease of the NtQ-amidase activity and the Ntaq1 protein among the above 3T3-
derived cell lines that expressed Ntaq1-specific pre-miRNAs. The oligonucleotides used are 
shown below. The underlined sequences were derived from the mouse miR-155 miRNA. 
Italicized sequences were derived from the mouse Ntaq1 mRNA (Acc.# BC051524): 
A-forward: 
TGCTGTTTCCTCCTAAACTGCAGATGGTTTTGGCCACTGACTGACCATCTGCATTAGGAG
GAAA. A-reverse: 
CCTGTTTCCTCCTAATGCAGATGGTCAGTCAGTGGCCAAAACCATCTGCAGTTTAGG
AGGAAAC. B-forward: 
TGCTGAGCTGTTGTAGACACATGCGTGTTTTGGCCACTGACTGACACGCATGTCTACAA
CAGCT. B-reverse: 
CCTGAGCTGTTGTAGACATGCGTGTCAGTCAGTGGCCAAAACACGCATGTGTCTACA
ACAGCTC. C-forward: 
TGCTGTTCCCTTGACACATGAAGCAGGTTTTGGCCACTGACTGACCTGCTTCATGTCAAG
GGAA. C-reverse: 
CCTGTTCCCTTGACATGAAGCAGGTCAGTCAGTGGCCAAAACCTGCTTCATGTGTCA
AGGGAAC. D-forward: 
TGCTGATCACAGGTCCATTCTCAGGTGTTTTGGCCACTGACTGACACCTGAGAGGACCT
GTGAT. D-reversed: 
CCTGATCACAGGTCCTCTCAGGTGTCAGTCAGTGGCCAAAACACCTGAGAATGGAC
CTGTGATC 
 
Antibody to Mouse Ntaq1 and Its Use to Deplete Ntaq1 in Cell Extracts 
 Mouse Ntaq1 purified from the yeast P. pastoris (see above and Figure 2E) was dialyzed 
against phosphate-buffered saline (PBS) (2.7 mM KCl, 137 mM NaCl, 1.5 mM KH2PO4, 8.1 
mM Na2HPO4, pH 7.3), and frozen in liquid N2. The resulting samples (4 mg total, at ~1 mg/ml) 
were sent to Abgent (San Diego, CA) for preparing rabbit polyclonal antibodies to mouse Ntaq1, 
using the Premiere PACS II protocol. Both preimmune and anti-Ntaq1 sera received from 
Abgent were stored at -80°C before use. For affinity purification of anti-Ntaq1 antibody, purified 
mouse Ntaq1 (Figure 2E) (10 mg, in 5 ml of gel filtration buffer (see above)) were dialyzed 
against 0.1 M MOPS, pH 7.5. The resulting sample was concentrated to the final volume of 2 ml, 
using Centricon (10 kDa cutoff, Millipore), followed by the addition of 0.5 ml of Affi-Gel 15 
(BioRad, Hercules, CA) and gentle rocking of the suspension at 4°C for 4 hr. The Affi-Gel gel 
slurry was thereafter washed with 0.1 M MOPS, pH 7.5, and unreacted Affi-Gel was blocked by 
incubation with 0.5 ethanolamine-HCl (pH 7.5) for 2 hr at 4°C. The coupling efficiency was 
~80% (16 mg of Ntaq1 per ml of Affi-Gel 15), as determined using Bradford assay to measure 
the amount of free (unconjugated) Ntaq1. Immobilized Ntaq1 (4 mg in 0.25 ml of settled Affi-
Gel suspension) was washed with PBS containing 0.2% Tween-20, and thereafter mixed with 5 
ml of anti-Ntaq1 IgG (~30 mg of total protein in PBS) that was produced using affinity 
chromatography on Protein A-Sepharose (GE Healthcare). The slurry was incubated, with gentle 
rocking, overnight at 4°C, followed by the transfer to a 1-ml column, washes (twice) with 10 ml 
of PBS (containing 0.2% Tween-20), and the elution of anti-Ntaq1 antibody with 0.2 M glycine-
HCl (pH 2.5). 0.5 ml fractions were collected into microcentrifuge tubes containing 0.1 ml of 1 
M K2HPO4 (pH 7.5). Protein-containing fractions were pooled, concentrated using Centricon (30 
kDa cutoff), and stored in 25- μl samples at -80°C. 
 For immunodepletion experiments, 0.8 ml of an extract from mouse NIH-3T3 cells in a 
lysis buffer (produced as described in the section about NtQ-amidase assay with X-DHFRbt 
reporters) was incubated two times at 4°C, for 45 min each time, with 40 μl of GammaBindTM 
G Sepharose (GE Healthcare) that had been preincubated for 1 hr min at 4°C either with 0.3 ml 
of rabbit preimmune serum (mock-depleted control) or 0.3 ml of the affinity-purified antibody to 
mouse Ntaq1. The two supernatants that resulted from these incubations were passed through 
spin columns (Pierce, Rockford, IL) that were equilibrated with wash buffer (5% glycerol, 0.2 M 
NaCl, 1 mM DTT, 20 mM NaH2PO4-Na2HPO4, pH 7.8). The total protein concentration in each 
sample was then adjusted to 0.8 mg/ml with wash buffer, followed by measurements of the NtQ-
amidase activity mainly as described in the legend to Figure 1B. The amounts or reporter and 
extract used (20 μg of a biotinylated X-DHFRbt reporter protein and 80 μg of protein in a 
(processed) extract) were optimized in preliminary experiments. 
 
Three-Dimensional Structure Alignment 
 Ntaq1 spalogs (see Introduction for terminology) in the Entrez PDB database were 
determined by direct comparison of 3D protein structures using the VAST algorithm (Gibrat et 
al., 1996; Madej et al., 2007) and full-length human Ntaq1 (PDB 3C9Q_A, residues 1-205). 
(http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.shtml). Spatial alignment between human 
Ntaq1 (PDB 3C9Q_A) and human Factor XIII  transglutaminase (PDB 1FIE_A) was carried out  
using  RAPIDO algorithm (http://webapps.embl-hamburg.de/rapido) (Mosca and Schneider, 
2008) and drawn using PyMOL (DeLano Scientific LLC, Palo Alto, CA).  
 
 
 
 Figure S1. The S. cerevisiae NtN,Q-amidase Nta1 As a Member of the Nitrilase Superfamily.  
 ClustalW2-based (http://www.clustal.org/) sequence alignments of S. cerevisiae Nta1 and 
some members of the carbon-nitrogen hydrolase family (Acc #: cl10026), a subset of the nitrilase 
superfamily (Brenner, 2002; Pace and Brenner, 2001). Abbreviations: yNta, Saccharomyces 
cerevisiae N-terminal amidase Nta1 (Acc #: AAB59320); Ps_fl, Pseudomonas fluorescens 
carbon-nitrogen hydrolase UPF0012 (Acc #: P55176); Al_am_Pao, Pseudomonas aeruginosa 
aliphatic amidase AmiE (Acc #: P11436); Nit4_At, Arabidopsis thaliana bifunctional 
nitrilase/nitrile hydratase NIT4 (Acc #: P46011); AmH_Agro, Agrobacterium tumefaciens N-
carbamoyl-D-amino-acid amidohydrolase HyuC1 (Acc #: 2BA5_B). The Glu, Lys and Cys 
residues of the conserved E-K-C catalytic triad are indicated by rectangles. Asterisks (*) denote 
identical residues among compared sequences; (:) denote similar residues; (.) denote weak 
similarities among compared sequences. 
 
 
Figure S2. NtN,Q-amidase Assay with X-DHFR Reporters. 
 (A) The plasmids termed pH10UE-X-DHFR-BAT were constructed to express in E. coli, 
from the phage T7 promoter, a set of C-terminally biotinylated E. coli DHFR-based reporters, 
His10-Ub-XLTKCEV-DHFRbt (X = Q; E; N; MQ; EQ; GQ; REQ), which contained the 
N-terminal His10-Ub moiety; the GGGLNDIFEAQKIEWHE C-terminal extension (denoted as 
bt) that was biotinylated in vivo by the E. coli BirA biotin-protein ligase (Beckett et al., 1999); 
the internal E. coli DHFR moiety; and the set of sequences XLTKCEV between the His10-Ub 
and DHFR moieties (see Experimental Procedures, Figure 1B and the main text). The lengths of 
depicted ORFs and other genetic elements are not to scale. 
 (B) Detection of the mouse NtQ-amidase activity in cell extracts. Lanes 1-6 are identical 
to lanes 1-6 of the main-text Figure 2A, while lanes 7-21 are different. Lane 1, SDS-PAGE of 
14C-arginylated proteins in an extract of mouse NIH-3T3 cells containing the added Glu-DHFRbt 
reporter and processed as described in Figure 1B. Bands of 14C-labeled X-DHFR reporters are 
indicated on the left. Lane 2, same as lane 1 but with Met-DHFRbt. Lane 3, same as lane 1 but 
with Gln-DHFRbt. Lanes 4-6, same as lanes 1-3 but with mouse brain extract. Lanes 7-9, same 
as lanes 1-3 but with liver extract. Lanes 10-12, same as lanes 1-3 but with kidney extract. Lanes 
13-15, same as lanes 1-3 but with testis extract. Lanes 16-18, same as lanes 1-3 but with spleen 
extract. Lanes 19-21, same as lanes 1-3 but with heart extract. 
 
 
Figure S3. Purification of Ntaq1 NtN,Q-amidase and Its Nuclear/Cytosolic Location. 
 (A) DEAE chromatography, the first step of bovine Ntaq1 purification after fractionation 
of a calf brain extract with ammonium sulfate (see Figure 1C). The curves of total protein 
concentration and NtQ-amidase activity are in dark blue and magenta, respectively. The 
measurements were carried out in one of every three consecutive fractions. 
 (B) Gel filtration on Superdex-75, another fractionation step (see Figure 1C).  Same 
designations as in A. The measurements were carried out in one of every three consecutive 
fractions. 
 (C) DAPI (DNA-specific) fluorescence patterns of mouse NIH-3T3 cells transfected with 
a plasmid that expressed mouse Ntaq1-EGFP fusion. 
 (D) Same cells but EGFP-specific fluorescence. 
 (E) Merged images of C and D. 
 (F-H) Same as E but another set of cells. 
 
 
Figure S4. Both RNAi-Mediated Depletion of Ntaq1 and In Vitro Depletion of Ntaq1 
Decrease NtN,Q-amidase Activity 
 (A) Treatment with an Ntaq1-specific miRNA decreases NtQ-amidase activity in mouse 
cells. 14C-arginylation assays with purified R-transferase and either Met-DHFR (“M”), 
Glu-DHFR (“E”), or Gln-DHFR (“Q”) (Figure 1B) were carried with extracts from mouse 
NIH-3T3 cells that were either untreated or treated with a pre-miRNA specific for Ntaq1 mRNA 
(see Experimental Procedures), as described below and also in the diagram above halftone 
images. The NtQ-amidase activity was detected by comparing the arginylation of Glu-DHFRbt 
(“E”), a substrate of R-transferase (Figure 1A), to the arginylation of Gln-DHFRbt (“Q”), which 
can be arginylated only after its N-terminal deamidation (Figures 1B). Met-DHFR (“M”) was a 
negative control (N-terminal Met is not a substrate of R-transferase; Figure 1A). Lane 1-3, buffer 
alone, with M, E, Q X-DHFR reporters. Only Glu-DHFRbt (“E”) is arginylated, by the added 
R-transferase,  in the absence of NtQ-amidase activity. Lanes 4-6, same as lane 1 but with an 
extract from a 3T3-derived cell line that was stably transfected with vector alone (see 
Experimental Procedures). Note the presence of NtQ-amidase activity. The level 14C-arginylation 
is higher in the (“E”) lane 5 than in the (“Q”) lane 6 because all of the present Glu-DHFRbt 
(“E”) reporter (lane 5) is a substrate of the added R-transferase, whereas only some of the 
Gln-DHFRbt (“Q”) reporter (lane 6) is deamidated in the cell extract to yield Glu-DHFRbt. 
Lanes 7-9, same as lanes 4-6, but after depletion of Ntaq1 from cell extracts with 
affinity-purified anti-Ntaq1 antibody (see Experimental Procedures, Figure 5A, and panels C-E 
below). Note the absence of NtQ-amidase activity. Lanes 10-12, same as lanes 4-6, but with a 
3T3-derived cell line, termed A2, that was stably transfected with a plasmid expressing one of 
four tested pre-miRNAs (see Experimental Procedures). Note a strong decrease of NtQ-amidase 
activity. Lanes 13-15, same as lanes 10-12, but the extract from cells subjected to Ntaq1-specific 
RNAi was additionally treated with antibody to Ntaq1. Note the absence of NtQ-amidase activity, 
similarly to a test with antibody-depletion only, without RNAi treatment of cells. 
(B) Lane 1, SDS-PAGE and immunoblotting with anti-Ntaq1 antibody of the extract 
from 3T3 cells in panel A, lanes 4-6 (transfection with vector alone). The band of Ntaq1 is 
indicated (see also panels C-E below). Lane 2, same as lane 1 but with the extract from cells in 
lanes 10-12 of panel A (transfection with Ntaq1-specific pre-miRNA). Note a close 
correspondence between a strongly decreased but still present NtQ-amidase activity in lane 12 of 
panel A and a strongly decreased but still (barely) detectable band of Ntaq1 in lane 2 of the 
present panel. 
 (C) Lanes 1-3, depletion of the endogenous Ntaq1 NtQ-amidase from extracts of mouse 
NIH-3T3 cells with affinity-purified antibody to mouse Ntaq1 (see Experimental Procedures and 
Figure 5A). Lane 1, immunoblotting, with antibody to Ntaq1 after SDS-PAGE, of proteins in a 
cell extract that had not been treated with anti-Ntaq1 antibody. The band of Ntaq1 is indicated. 
Lane 2, same as lane 1, but the extract was depleted with preimmune serum before SDS-PAGE 
and immunoblotting with anti-Ntaq1 antibody. Lane 3, same as lane 2 but depletion with 
anti-Ntaq1 antibody. 
 (D, E) Loading controls: immunoblotting with anti-tubulin antibody (panel D) and 
staining with Coomassie of SDS-PAGE-fractionated proteins before immunoblotting (panel E). 
 
  
Figure S5. Sequelogs of the Mouse Ntaq1 NtN,Q-amidase in Other Multicellular Eukaryotes 
and Fission Yeast. 
 ClustalW2-based (http://www.clustal.org/) sequence alignments of mouse (Mus) Ntaq1 
and its sequelogs in other organisms. Rattus, rat (R. norvegicus). Bos, cow (B. taurus). Homo, 
human (H. sapiens). Danio, zebrafish (D. rerio). Xenopus, frog (X. laevis). Drosophila, fruit fly 
(D. melanogaster). Arabidopsis (A. thaliana), a member of the mustard (Brassicaceae) family. 
Caenorhabditis, nematode (C. elegans). Schizosaccharomyces, fission yeast (S. pombe). Three 
rectangles indicate positions of three key residues in the (inferred) catalytic triade of Ntaq1 
(Cys30, His83 and Asp99 in mouse Ntaq1; see the main text). 
 
Table S1. Some of the plasmids used in this study. 
 
Plasmids Characteristics Reference or primers 
pUB23-Met Ub-Met-βgal (Bachmair et al., 1986) 
pUB23-Arg Ub-Arg-βgal (Bachmair et al., 1986) 
pUB23-Asp Ub-Asp-βgal (Bachmair et al., 1986) 
pUB23-Asn Ub-Asn-βgal (Bachmair et al., 1986) 
pUB23-Glu Ub-Glu-βgal (Bachmair et al., 1986) 
pUB23-Gln Ub-Gln-βgal (Bachmair et al., 1986) 
p425MET25 2-micron; PMet25 promoter (Mumberg et al., 1994) 
p425MET25_yNTA1_Flag S. cerevisiae Nta1-flag HW-4-44I; HW-4-44L 
p425MET25_mNTAQ1_Flag mouse Ntaq1-flag HW-5-22A; HW-5-22B 
p425MET25_mNTAN1_Flag mouse Ntan1-flag HW-4-44G; HW-4-44K 
p425MET25_mHEBP2_Flag mouse Hebp2-flag HW-5-22J; HW-5-22K; 
HW-5-22N; HW-5-22M 
pBirAcm BirA Avidity, Inc. 
pH10UE Ub fusion vector (Catanzariti et al., 2004) 
pH10UE_EQLTKCEV_DHFR_BAT X-DHFRbt HW-4-98A; HW-4-98F; 
HW-4-98G 
pH10UE-MQLTKCEV-DHFR-BAT X-DHFRbt HW-4-98B; HW-4-98H 
pH10UE-GQLTKCEV-DHFR-BAT X-DHFRbt HW-4-98N; HW-4-98H 
pH10UE_QLTKCEV_DHFR_BAT X-DHFRbt HW-4-98N; HW-4-98H 
pH10UE_DLTKCEV_DHFR_BAT X-DHFRbt HW-4-98K; HW-4-98H 
pH10UE_NLTKCEV_DHFR_BAT X-DHFRbt HW-4-98L; HW-4-98H 
pH10UE_MLTKCEV_DHFR_BAT X-DHFRbt HW-4-98M; HW-4-98H 
pH10UE_NLTKCEV_DHFR X-DHFRbt HW-4-98L;  HW-4-98K1 
pH10UE_QLTKCEV_DHFR X-DHFRbt HW-4-98E; HW-4-98K1 
pPICZaC ZeocinR Invitrogen 
PPICZaC_NTAQ1_His mouse Ntaq1-His6 HW-5-46D; HW-45-46B 
PPICZaC_NTAQ1_His E39Q Ntaq1-E39Q HW-5-68K; HW-5-68L 
PPICZaC_NTAQ1_His D81N Ntaq1-D81N HW-5-68M; HW-5-68N 
PPICZaC_NTAQ1_His H83A Ntaq1-H83A HW-5-68O; HW-5-68P 
PPICZaC_NTAQ1_His D147N Ntaq1-D147N HW-5-68Q; HW-5-68R 
PPICZaC_NTAQ1_His C23A Ntaq1-C23A HW-5-68A; HW-5-68B 
PPICZaC_NTAQ1_His C28A Ntaq1-C28A HW-5-68C; HW-5-68D 
PPICZaC_NTAQ1_His C28A C30A Ntaq1-C28A, C30A HW-5-68G; HW-5-68H 
PPICZaC_NTAQ1_His C30A Ntaq1- C30A HW-5-68E; HW-5-68F 
PPICZaC_NTAQ1_His C38A Ntaq1- C38A HW-5-68I; HW-5-68J 
PPICZaC_NTAQ1_His H150A Ntaq1- H150A HW-5-68S; HW-5-68T 
pEGFP-N1 KanR, NeoR Clontech 
pEGFP_mNTAQ1 Ntaq1-EGFP HW-5-64A; HW-5-64B 
 
 
  
Table S2. Some of the primers used in this study. 
 
 Primer Sequence 
1 HW-4-44G CAG GGA TCC ATG CCA CTG CTG GTG GAT GGG C 
2 HW-4-44I CAG GGA TCC ATG CTA ATA GAC GCA ATT CAT GG 
3 HW-4-44K 
CTG CTC GAG TTA CTT ATC GTC GTC ATC CTT GTA  
ATC GCT CCC TGG AGA GGA G 
4 HW-4-44L 
CTG CTC GAG TCA CTT ATC GTC GTC ATC CTT GTA  
ATC CCT AAA CAC TTC AAA TTG GAC 
5 HW-4-98A 
CTC CGC GGT GGT GAA CAG TTA ACA AAA TGT GAG  
GTG ATC AGT CTG ATT GCG GCG TTA GC 
6 HW-4-98B CTC CGC GGT GGT ATG CAG TTA ACA AAA TGT GAG 
7 HW-4-98E CTC CGC GGT GGT CAG TTA ACA AAA TGT GAG GTG 
8 HW-4-98F 
GGC CTC GAA GAT GTC GTT CAG ACC GCC ACC CCG  
CCG CTC CAG AAT CTC AAA GCA 
9 HW-4-98G 
GTA AAG CTT TCA CTC GTG CCA CTC GAT CTT CTG  
GGC CTC GAA GAT GTC GTT CAG 
10 HW-4-98H GTA AAG CTT TCA CTC GTG CCA CTC GAT CTT  
11 HW-4-98K CTC CGC GGT GGT GAC TTA ACA AAA TGT GAG GTG 
12 HW-4-98L CTC CGC GGT GGT AAC TTA ACA AAA TGT GAG GTG 
13 HW-4-98M CTC CGC GGT GGT ATG TTA ACA AAA TGT GAG GTG 
14 HW-4-98N CTC CGC GGT GGT GGT CAG TTA ACA AAA TGT GAG 
15 HW-4-98K1 GTA AAG CCT TTA CCG CCG CTC CAG AAT CTC 
16 HW-5-22A ATT GGA TCC ATG GAG GGG GAC GGC CC 
17 HW-5-22B 
CTG CTC GAG TCA CTT ATC GTC GTC ATC CTT GTA  
ATC GGC TTG GTA GGT TTT GCT GCT G 
18 HW-5-22J ATT GGA TCC ATG GCA GAG GAG CCG GAG CCA 
19 HW-5-22K 
CTG CTC GAG TCA CTT ATC GTC GTC ATC CTT GTA  
ATC TTT GTT CTC GAC GGA GGG C 
20 HW-5-22M 
GTT GTT CTT GAT TCT TTT GGC CAC TGG AGA ATC  
CAT CAA 
21 HW-5-22N 
TTG ATG GAT TCT CCA GTG GCC AAA AGA ATC AAG  
AAC AAC 
22 HW-5-46B ATG GTC GAC AGC TTG GTA GGT TTT GCT GC 
23 HW-5-46D A GCA TCG ATG GAG GGG GAC GGC 
24 HW-5-58A AC AAG CTT ATG GAC TAC AAG GAC GAC GAT GAC 
25 HW-5-58B GAG CGG CCG CCT ATC CGC CGC GGA GCC TTA GCA C 
26 HW-5-58C CTC CGC GGC GGA CAG AAG AGC AAA GCA GAT TAT 
27 HW-5-58E CTC CGC GGC GGA GAG AAG AGC AAA GCA GAT TAT 
28 HW-5-58F CTC CGC GGC GGA AGA AAG AGC AAA GCA GAT TAT 
29 HW-5-58G CTC CGC GGC GGA ATG AAG AGC AAA GCA GAT TAT 
30 HW-5-58H CTC CGC GGC GGA TAC AAG AGC AAA GCA GAT TAT 
31 HW-5-58J CTC CGC GGC GGA GAC AAG AGC AAA GCA GAT TAT 
32 HW-5-58C1 
TGC TCG AGC TAA CCC TTG TCA TCG TCG TCC TTG TAG  
TCT AAT TTT TTA TAG AAT AGC AAG TAG GGA 
33 HW-5-64A ATC TCG AGA TGG AGG GGG ACG GCC C 
34 HW-5-64B GCC CGC GGG GCT TGG TAG GTT TTG CTG CTG AA 
35 HW-5-68A GTC TGT CCT ACG CGG GAC GCA GCT GTC TAC AAC A 
36 HW-5-68B ACA ATA GCA GCT GTT GTA GAC AGC TGC GTC CCG C 
37 HW-5-68C GAC GCA TGT GTC TAC AAC AGC GCC TAT TGT GAG G 
38 HW-5-68D CAA ATG TTT TCC TCA CAA TAG GCG CTG TTG TAG 
39 HW-5-68E TGT GTC TAC AAC AGC TGC TAT GCT GAG GAA AAC A 
40 HW-5-68F AGC TTC CAA ATG TTT TCC TCA GCA TAG CAG CTG 
41 HW-5-68G 
GAC GCA TGT GTC TAC AAC AGC GCC TAT GCT GAG  
GAA AAC A 
42 HW-5-68H 
AGC TTC CAA ATG TTT TCC TCA GCA TAG GCG CTG  
TTG TAG A 
43 HW-5-68I 
GAG GAA AAC ATT TGG AAG CTC GCT GAG TAC ATC 
AAG 
44 HW-5-68J GGT TGT GTG TCT TGA TGT ACT CAG CGA GCT TCC AAA 
45 HW-5-68K AAA CAT TTG GAA GCT CTG TCA ATA CAT CAA GAC 
46 HW-5-68L TGG TTG TGT GTC TTG ATG TAT TGA CAG AGC TTC C 
47 HW-5-68M AGA ATG GAC CTG TGA TCT GGA ACT ACC ATG TGG T 
48 HW-5-68N CAT GAA GCA GAA CCA CAT GGT AGT TCC AGA TCA CA 
49 HW-5-68O GGA CCT GTG ATC TGG GAC TAC GCT GTG GTT CTG CT 
50 HW-5-68P 
GAC ACA TGA AGC AGA ACC ACA GCG TAG TCC CAG 
ATC 
51 HW-5-68Q TAC TTG AAG CAC TTC GCT TCT AAC CGG TCT CAC A 
52 HW-5-68R GGA GTC TTT CAT GTG AGA CCG GTT AGA AGC GAA G 
53 HW-5-68S CAC TTC GCT TCT GAC CGG TCT GCC ATG AAA GAC T 
54 HW-5-68T TTC CCA CTG GAG TCT TTC ATG GCA GAC CGG TCA 
55 HW-4-44A 
GAT AAC TCT ATC GTG ACA TTC AGT GAC GGA TCC CCG 
GGT TAA TTA A 
56 HW-4-44A1 
GCA TTT CAA TGC TAA AAA GTG CTA GTT TAC AGC GAT 
AAC TCT ATC GTG ACA TTC 
57 HW-4-44B 
AAT GTC TAA TTT ATT ATA ATA TTC CTG AAT TCG AGC 
TCG TTT AAA C 
58 HW-4-44B1 
CAA TAA CAT AAA TAT GCG TGT AAC CTT ATT AAT TTA 
TAA TGT CTA ATT TAT TAT AAT 
59 HW-4-57A TTA CCC TGC ACC ATT CAA GAG 
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